Key result
Immune dysregulation and inflammation drive placental vascular remodeling and maternal cardiovascular dysfunction in preeclampsia.
This review outlines the critical role of immune mechanisms and inflammation in driving the aberrant vascular adaptations and maternal cardiovascular dysfunction seen in preeclampsia.
Preeclampsia is a multisystem vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. Preeclampsia affects 2% to 5% of pregnancies and is a major contributor to maternal and perinatal morbidity and mortality resulting from aberrant vascular and immunologic responses. While the exact mechanisms of why preeclampsia arises remain unclear, our current understanding suggests that inadequate vascular adaptations are a contributing factor to the disease. In this review, we focus on how immune system changes affect the onset and pathogenesis of preeclampsia, specifically in the context of placental vascular development and maternal cardiovascular dysfunction. We also discuss the potential direct link in preeclampsia between immune cells, inflammation, and how they impact placental vascular remodeling and maternal cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Christensen et al. (2025) conducted a review in Preeclampsia. Immune system changes and inflammation was evaluated. This review highlights how immune system changes and inflammation impact placental vascular remodeling and maternal cardiovascular dysfunction in the pathogenesis of preeclampsia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: